SEC Company Response from Revolution Medicines, Inc. (RVMD, RVMDW) (CIK 0001628171) (RVMD) — Feb 1, 2021
Revolution Medicines, Inc. (RVMD, RVMDW) (CIK 0001628171)
Date: Feb. 1, 2021 · CIK: 0001628171 · Accession: 0001193125-21-024601
AI Filing Summary & Sentiment
File numbers found in text: 333-252613
Letter
Revolution Medicines, Inc.
700 Saginaw Drive
Redwood City, California 94063
February 1, 2021
VIA EDGAR AND E-MAIL
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C.
Attention: David Gessert
Re: Revolution Medicines, Inc. Registration Statement on Form S-1 (Registration No. 333-252613)
Ladies and Gentlemen:
In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form S-1 (File No. 333-252613) (the “Registration Statement”) of Revolution Medicines, Inc. (the “Company”). We respectfully request that the Registration Statement become effective as of 4:30 p.m., Washington, D.C. time, on February 3, 2021, or as soon as practicable thereafter, or at such other time as our legal counsel, Latham & Watkins LLP, may request by telephone to the staff of the U.S. Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Latham & Watkins LLP, by calling Mark Roeder at (650) 463-3043.
Thank you for your assistance in this matter.
Very truly yours,
REVOLUTION MEDICINES, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP Revolution Medicines, Inc. 700 Saginaw Drive Redwood City, California 94063 February 1, 2021 VIA EDGAR AND E-MAIL United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: David Gessert Re: Revolution Medicines, Inc. Registration Statement on Form S-1 (Registration No. 333-252613) Ladies and Gentlemen: In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form S-1 (File No. 333-252613) (the “Registration Statement”) of Revolution Medicines, Inc. (the “Company”). We respectfully request that the Registration Statement become effective as of 4:30 p.m., Washington, D.C. time, on February 3, 2021, or as soon as practicable thereafter, or at such other time as our legal counsel, Latham & Watkins LLP, may request by telephone to the staff of the U.S. Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Latham & Watkins LLP, by calling Mark Roeder at (650) 463-3043. Thank you for your assistance in this matter. Very truly yours, REVOLUTION MEDICINES, INC. By: /s/ Margaret Horn Margaret Horn Chief Operating Officer and General Counsel CC: Mark A. Goldsmith, Revolution Medicines, Inc. Jeff Cislini, Revolution Medicines, Inc. Mark V. Roeder, Latham & Watkins LLP John C. Williams, Latham & Watkins LLP Alan F. Denenberg, Davis Polk & Wardwell LLP